Patriot Financial Group Insurance Agency LLC raised its holdings in shares of McKesson Co. (NYSE:MCK – Free Report) by 8.6% in the 1st quarter, Holdings Channel reports. The firm owned 1,713 shares of the company’s stock after purchasing an additional 135 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s holdings in McKesson were worth $1,153,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in MCK. Capital A Wealth Management LLC purchased a new position in shares of McKesson during the fourth quarter valued at $26,000. Millstone Evans Group LLC purchased a new position in shares of McKesson during the fourth quarter valued at $28,000. Atala Financial Inc purchased a new position in shares of McKesson during the fourth quarter valued at $34,000. Graney & King LLC purchased a new position in shares of McKesson during the fourth quarter valued at $38,000. Finally, Creative Capital Management Investments LLC purchased a new position in shares of McKesson during the fourth quarter valued at $44,000. 85.07% of the stock is currently owned by institutional investors.
McKesson Stock Performance
Shares of MCK stock opened at $712.99 on Monday. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $731.00. The firm has a market capitalization of $89.20 billion, a price-to-earnings ratio of 32.65, a PEG ratio of 1.29 and a beta of 0.49. The stock’s 50-day simple moving average is $699.69 and its 200-day simple moving average is $641.34.
McKesson Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. McKesson’s payout ratio is 10.99%.
Insider Transactions at McKesson
In related news, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the completion of the sale, the chief financial officer now owns 14,760 shares of the company’s stock, valued at $10,587,348. The trade was a 30.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Thomas L. Rodgers sold 2,891 shares of McKesson stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $712.18, for a total value of $2,058,912.38. Following the sale, the executive vice president now directly owns 2,544 shares of the company’s stock, valued at $1,811,785.92. This trade represents a 53.19% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,747 shares of company stock worth $9,852,587. Insiders own 0.11% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have recently commented on MCK. Bank of America raised their price target on McKesson from $755.00 to $800.00 and gave the company a “buy” rating in a research note on Friday, May 9th. Wall Street Zen upgraded McKesson from a “buy” rating to a “strong-buy” rating in a research note on Friday, May 30th. Mizuho raised their price target on McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a research note on Thursday, April 3rd. Cfra Research lowered McKesson from a “moderate buy” rating to a “hold” rating in a research note on Friday, April 4th. Finally, Wells Fargo & Company set a $766.00 target price on McKesson and gave the company an “equal weight” rating in a research note on Tuesday, June 3rd. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $692.46.
View Our Latest Analysis on MCK
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- What is Insider Trading? What You Can Learn from Insider Trading
- Five Below Pops on Strong Earnings, But Rally May Stall
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- CD Calculator: Certificate of Deposit Calculator
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.